Shuyan Chen

Dynamic changes in controlled attenuation parameter (CAP) improve prognostic prediction for CHB patients with significant fibrosis and cirrhosis

Xiaowei Ai, Mengyang Zhang, Shuyan Chen, Xinyu Zhao et autres

cn (code pays fourni par la source)

Su2156 SERUM THROMBOSPONDIN-2 IS A RELIABLE PREDICTOR OF IMPROVED LIVER FIBROSIS AND INFLAMMATION IN HBV PATIENTS UNDERGOING MULTIMODAL ANTIVIRAL THERAPY

Rambabu Surabattula, Shuyan Chen, Tongtong Meng, Sudharani Myneni et autres

Su2156 SERUM THROMBOSPONDIN-2 IS A RELIABLE PREDICTOR OF IMPROVED LIVER FIBROSIS AND INFLAMMATION IN HBV PATIENTS UNDERGOING MULTIMODAL ANTIVIRAL THERAPY

Rambabu Surabattula, Shuyan Chen, Tongtong Meng, Sudharani Myneni et autres

WED-040 Burden of liver fibrosis and steatosis associated with hepatitis B or C infection in China: a population-based study from the 2020 national serological survey

Tongtong Meng, Yu Wang, Hui Zheng, Jian Li et autres

ECM1 produced by hepatic stellate cells serves as a gatekeeper of liver homeostasis in hepatic fibrosis

Aiting Yang, Xuzhen Yan, Yiwen Wang, Qi Han et autres

BACKGROUND AND AIMS: Hepatic stellate cell (HSC) activation is central to liver fibrosis, but emerging evidence suggests HSC homeostatic activity. We compared HSC functions in parenchymal injury (CCl 4 -driven) versus metabolic dysfunction-associated steatohepatitis (MASH; choline-deficient, high-fat diet-CD-HFD) and identified therapeutic targets …

de, cn, fr, us (code pays fourni par la source)

Comparative efficacy of pharmacologic therapies for MASLD in improving fibrosis: systematic review and network meta-analysis

Xiao Han, Xiaowei Ai, Yameng Sun, Shuyan Chen et autres

Fibrosis is a key predictor of the long-term prognosis in metabolic dysfunction-associated steatotic liver disease (MASLD). Numerous clinical trials in drug development for MASLD have used fibrosis improvement as an efficacy endpoint. We aim to compare the efficacy of pharmacologic therapies for …

cn (code pays fourni par la source)

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies

Shuyan Chen, Jialing Zhou, Bingqiong Wang, Xiaoning Wu et autres

Background/Aims: Noninvasive indexes can be used to diagnose and stage liver fibrosis caused by chronic hepatitis B (CHB). We aimed to evaluate whether changes in the liver stiffness measurement (LSM) and serum biomarkers can predict liver fibrosis regression in CHB patients based …

cn (code pays fourni par la source)

Unstable Recompensation: An Intermediate Subtype in Patients With HBV ‐Related Decompensated Cirrhosis

Shuai Xia, Zhiying He, Xiaoning Wu, Zhongjie Hu et autres

BACKGROUND AND AIM: Recent studies show that patients with hepatitis B virus (HBV)-related decompensated cirrhosis who achieve recompensation can still experience further decompensation, suggesting that recompensation status can change over time. This study aimed to classify patterns of recompensation and charaterize the …

cn (code pays fourni par la source)

Reply: Clarifying LSM cutoff validation, statistical power, and subgroup applicability in predicting liver-related events in chronic hepatitis B

Yameng Sun, Shuyan Chen, Xinyu Zhao

cn (code pays fourni par la source)

Doping and defect engineering synergistically enhance sodium ion storage in surface-amorphized MnO2

Jie Hu, Shuyan Chen, Qiyan Zhao, Xunping Zhou et autres

cn (code pays fourni par la source)

LFM Carrier Enabled Integrated Sensing and Communication in Self-homodyne Coherent Detection Transmission System

Shuyan Chen, Bowen Yin, Huan He, Yang Shi et autres

We demonstrate integrated communication (25-Gbaud DP-16QAM,$2-\text{cm}$spatial resolution) over 10-km MCF using linear-frequency-modulated carriers and self-homodyne coherent detection. Simultaneous optical multipath interference, transmission loss, and vibration monitoring are achieved without spectral overhead. ©2025 The Author(s)

cn (code pays fourni par la source)

The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-Treatment Patients With Chronic Hepatitis B

Xiaoning Wu, Jialing Zhou, Yameng Sun, Chenghai Liu et autres

cn (code pays fourni par la source)